国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudomonas aeruginosa Flagellum-specific ATP synthase (fliI) CSB-YP862279EZX
CSB-EP862279EZX
CSB-BP862279EZX
CSB-MP862279EZX
CSB-EP862279EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Acyl-homoserine lactone acylase quiP (quiP), partial CSB-YP862280EZX
CSB-EP862280EZX
CSB-BP862280EZX
CSB-MP862280EZX
CSB-EP862280EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Proline--tRNA ligase (proS), partial CSB-YP862281EZX
CSB-EP862281EZX
CSB-BP862281EZX
CSB-MP862281EZX
CSB-EP862281EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Neutral ceramidase (PA0845), partial CSB-YP862282EZX
CSB-EP862282EZX
CSB-BP862282EZX
CSB-MP862282EZX
CSB-EP862282EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa UPF0350 protein PA0760 (PA0760) CSB-YP862283EZX
CSB-EP862283EZX
CSB-BP862283EZX
CSB-MP862283EZX
CSB-EP862283EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase (coq7) CSB-YP862284EZX
CSB-EP862284EZX
CSB-BP862284EZX
CSB-MP862284EZX
CSB-EP862284EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Bis (5'-nucleosyl)-tetraphosphatase, symmetrical (apaH) CSB-YP862285EZX
CSB-EP862285EZX
CSB-BP862285EZX
CSB-MP862285EZX
CSB-EP862285EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Fructose-bisphosphate aldolase (fba) CSB-YP862286EZX
CSB-EP862286EZX
CSB-BP862286EZX
CSB-MP862286EZX
CSB-EP862286EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Putative esterase PA0474 (PA0474) CSB-YP862287EZX
CSB-EP862287EZX
CSB-BP862287EZX
CSB-MP862287EZX
CSB-EP862287EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Dihydroxy-acid dehydratase (ilvD), partial CSB-YP862288EZX
CSB-EP862288EZX
CSB-BP862288EZX
CSB-MP862288EZX
CSB-EP862288EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 3-carboxy-cis,cis-muconate cycloisomerase (pcaB) CSB-YP862289EZX
CSB-EP862289EZX
CSB-BP862289EZX
CSB-MP862289EZX
CSB-EP862289EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Adenine deaminase (PA0148) CSB-YP862290EZX
CSB-EP862290EZX
CSB-BP862290EZX
CSB-MP862290EZX
CSB-EP862290EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Probable RNA 2'-phosphotransferase (kptA) CSB-YP862291EZX
CSB-EP862291EZX
CSB-BP862291EZX
CSB-MP862291EZX
CSB-EP862291EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP862292EZX
CSB-EP862292EZX
CSB-BP862292EZX
CSB-MP862292EZX
CSB-EP862292EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Tyrosine-protein kinase PR2 (PR2), partial CSB-YP862293DLU
CSB-EP862293DLU
CSB-BP862293DLU
CSB-MP862293DLU
CSB-EP862293DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster La-related protein CG11505 (CG11505), partial CSB-YP862294DLU
CSB-EP862294DLU
CSB-BP862294DLU
CSB-MP862294DLU
CSB-EP862294DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laticauda semifasciata Phospholipase A2 GL1-1 CSB-YP862295LDC
CSB-EP862295LDC
CSB-BP862295LDC
CSB-MP862295LDC
CSB-EP862295LDC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laticauda semifasciata Phospholipase A2 cL037 CSB-YP862296LDC
CSB-EP862296LDC
CSB-BP862296LDC
CSB-MP862296LDC
CSB-EP862296LDC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chicken V-type proton ATPase 116 kDa subunit a isoform 1 (ATP6V0A1), partial CSB-YP862297CH
CSB-EP862297CH
CSB-BP862297CH
CSB-MP862297CH
CSB-EP862297CH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chicken Bcl-2-related ovarian killer protein (BOK) CSB-YP862298CH
CSB-EP862298CH
CSB-BP862298CH
CSB-MP862298CH
CSB-EP862298CH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>